Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma

Japanese Journal of Cancer Research

Volumn 93, Issue 10, 2002, Pages 1123-1128

  Kang, Sung Soo ^a   Chun, Yi Kyeong ^a   Hur, Min Hee ^a   Lee, Hae Kyung ^a   Kim, Yee Jeong ^a   Hong, Sung Ran ^a   Lee, Jee Hyun ^a   Lee, Sung Gong ^a   Park, Yong Koo ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Breast carcinoma; GLUT1; Immunohistochemistry; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; GLUCOSE; GLUCOSE TRANSPORTER 1; PROGESTERONE RECEPTOR; TAMOXIFEN; GLUCOSE TRANSPORTER; SLC2A1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC MARKER; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR VOLUME; BREAST TUMOR; CHEMISTRY; FEMALE; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; PROGNOSIS; RECEPTORS, PROGESTERONE; SURVIVAL RATE;

EID: 0036808431     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01214.x     Document Type: Article

References (26)

1. Warberg, O. On the origin of cancer cells. Science, 123, 306-314 (1956).
2. Smith, T. A. D. Facilitative glucose transporter expression in human cancer tissue. Br. J. Biomed. Sci., 56, 285-292 (1999).
3. Zamora-Leon, S., Golde, D., Concha II, Rivas, C., Delgado-Lopez, F., Baselga, J., Nualart, F. and Vera, J. Expression of the fructose transporter GLUT5 in human breast cancer. Proc. Natl. Acad. Sci. USA, 93, 1847-1852 (1996).
4. Grover-McKay, M., Walsh, S., Seftor, E., Thomas, P. and Hendrix, M. Role of glucose transporter 1 in human breast cancer. Pathol. Oncol. Res., 4 (2), 115-120 (1998).
5. Younes, M., Lechago, L. and Lechago, J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin. Cancer Res., 2, 1151-1154 (1996).
6. Haber, R., Rathan, A., Weiser, K., Pritsker, A., Itzkowitz, S., Bodian, C., Slater, G., Weiss, A. and Burstein, D. GLUT1 glucose transporter expression in colorectal carcinoma; a marker for poor prognosis. Cancer, 83, 34-40 (1998).
7. Sakashita, M., Aoyama, N., Minami, R., Maekawa, S., Kuroda, K., Shirasaka, D., Ichihara, T., Kuroda, Y., Maeda, S. and Kasuga, M. GLUT1 expression in T1 and T2 stage colorectal carcinomas; its relationship to clinicopathological features. Eur. J. Cancer, 37, 204-209 (2001).
8. Furudoi, A., Tanaka, S., Haruma, K., Yoshihara, M., Sumii, K., Kajiyama, G. and Shimamoto, F. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma. Oncology, 60, 162-169 (2001).
9. Haber, R., Weiser, K., Pritsker, A., Reder, I. and Burstein, D. GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid, 7, 363-367 (1997).
10. Younes, M., Brown, R., Stephenson, M., Gondo, M. and Cagle, P. Overexpression of GLUT1 and GLUT3 in stage 1 non-small cell lung carcinoma is associated with poor survival. Cancer, 80, 1046-1051 (1997).
11. Ito, T., Noguchi, Y., Satoh, S., Hayashi, H., Inayama, Y. and Kitamura, H. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Mod. Pathol., 11, 437-443 (1998).
12. Noguchi, Y., Marat, D., Yoshigawa, T., Doi, C., Fukuzawa, K., Tsuburaya, A., Satoh, S. and Ito, T. Expression of facilitative glucose transporters in gastric tumors. Hepatogastroenterology, 46, 2683-2689 (1999).
13. Reisser, C., Eichhorn, K., Herold-Mende, C., Born, A. and Bannasch, P. Expression of facilitative glucose transporter proteins during development of squamous cell carcinoma of the head and neck. Int. J. Cancer, 80, 194-198 (1999).
14. Chang, S., Lee, S., Lee, C., Kim, J. and Kim, Y. Expression of human erythrocyte glucose transporter in transitional cell carcinoma of the bladder. Urology, 55, 448-452 (2000).
15. Younes, M., Juarez, D., Lechago, L. and Lerner, S. GLUT1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res., 21, 575-578 (2001).
16. Nagase, Y., Takata, K., Moriyama, N., Aso, Y., Murakami, T. and Hirano, H. Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J. Urol., 153, 798-801 (1995).
17. Wang, B., Kalir, T., Sabo, E., Sherman, D., Cohen, C. and Burstein, D. Immunohistochemical staining of GLUT1 in benign hyperplastic, and malignant endometrial endothelia. Cancer, 88, 2774-2781 (2000).
18. Fisher, E., Gregorio, R., Fisher, B., Redmond, C., Vellios, F. and Sommers, S. The pathology of National Surgical Adjuvant Breast Project (Protocol 4). Cancer, 36, 1-85 (1975).
19. Mueckler, M. Facilitative glucose transporters. Eur. J. Biochem., 219, 713-725 (1994).
20. Flier, J., Mueckler, M., Usher, P. and Lodish, H. Elevated levels of glucose transport and transporter messenger RNA are induced ras or src oncogenes. Science, 235, 1492-1495 (1987).
21. Rollins, B., Morrison, E., Usher, P. and Flier, J. Platelet-derived growth factor regulates glucose transporter expression. J. Biol. Chem., 263, 16523-16526 (1988).
22. Merrall, N., Plevin, R. and Gould, G. Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell. Signal., 5, 667-675 (1993).
23. Younes, M., Brown, R., Mody, D., Fernandez, L. and Laucirica, R. GLUT1 expression in human breast carcinoma correlates with human prognostic markers. Anticancer Res., 15, 2895-2898 (1995).
24. Brown, R. and Wahl, R. Overexpression of glut1 glucose transporter in human breast cancer. An immunochemical study. Cancer, 72, 2979-2985 (1993).
25. Alo, P., Botti, C., Galati, G., Sebastiani, V., Andreano, T., Di Tondo, U. and Pizer, E. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am. J. Clin. Pathol., 116, 129-134 (2001).
26. Binder, C., Binder, L., Schauer, A. and Hiddemann, W. Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues. Anti-cancer Res., 17, 4299-4304 (1997).